ZA9610426B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA9610426B ZA9610426B ZA9610426A ZA9610426A ZA9610426B ZA 9610426 B ZA9610426 B ZA 9610426B ZA 9610426 A ZA9610426 A ZA 9610426A ZA 9610426 A ZA9610426 A ZA 9610426A ZA 9610426 B ZA9610426 B ZA 9610426B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9525194.8A GB9525194D0 (en) | 1995-12-12 | 1995-12-12 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9610426B true ZA9610426B (en) | 1997-06-23 |
Family
ID=10785178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9610426A ZA9610426B (en) | 1995-12-12 | 1996-12-11 | Pharmaceutical composition |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU1039097A (en) |
GB (1) | GB9525194D0 (en) |
WO (1) | WO1997021440A1 (en) |
ZA (1) | ZA9610426B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000313D0 (en) * | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
RU2004102393A (en) * | 2001-07-07 | 2005-03-27 | Астразенека Аб (Se) | PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INTRODUCTION OF A FULVESTRANT |
CA2492079C (en) | 2002-07-24 | 2012-01-10 | Schering Aktiengesellschaft | Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids |
DE10247399A1 (en) * | 2002-10-08 | 2004-04-29 | Schering Ag | Pharmaceutical preparations, use of this preparation and methods for increasing the bioavailability of drugs to be administered orally |
WO2007033434A1 (en) * | 2005-09-26 | 2007-03-29 | Hospira Australia Pty Ltd | Fulvestrant formulation |
KR20100121505A (en) * | 2008-03-07 | 2010-11-17 | 싸이도우스 엘엘씨. | Fulvestrant formulations |
CA2779005A1 (en) | 2009-11-09 | 2011-05-12 | Capsugel Belgium Nv | Delivery carrier |
US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
CN108883118B (en) | 2016-04-06 | 2021-06-15 | 富士胶片株式会社 | Pharmaceutical composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
-
1995
- 1995-12-12 GB GBGB9525194.8A patent/GB9525194D0/en active Pending
-
1996
- 1996-12-09 WO PCT/GB1996/003022 patent/WO1997021440A1/en active Application Filing
- 1996-12-09 AU AU10390/97A patent/AU1039097A/en not_active Abandoned
- 1996-12-11 ZA ZA9610426A patent/ZA9610426B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9525194D0 (en) | 1996-02-07 |
AU1039097A (en) | 1997-07-03 |
WO1997021440A1 (en) | 1997-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601698D0 (en) | Pharmaceutical composition | |
HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
ZA967827B (en) | Pharmaceutical compositions | |
GB9519667D0 (en) | Pharmaceutical composition | |
ZA962214B (en) | Pharmaceutical composition | |
ZA963590B (en) | Pharmaceutical composition | |
EG24294A (en) | Pharmaceutical compositions | |
GB9506382D0 (en) | Pharmaceutical compositions | |
GB9513972D0 (en) | Pharmaceutical compositions | |
ZA96525B (en) | Novel pharmaceutical compositions | |
ZA9610426B (en) | Pharmaceutical composition | |
GB9502695D0 (en) | Pharmaceutical composition | |
ZA964193B (en) | Pharmaceutical composition | |
HU9602822D0 (en) | Pharmaceutical composition | |
ZA963591B (en) | Pharmaceutical composition | |
ZA95736B (en) | Pharmaceutical composition | |
HUP9602732A2 (en) | Pharmaceutical composition comprising lanperisone | |
GB9517063D0 (en) | Pharmaceutical composition | |
GB9505368D0 (en) | Pharmaceutical composition | |
ZA9510132B (en) | Pharmaceutical composition | |
HU9903430D0 (en) | Pharmaceutical composition | |
GB9519748D0 (en) | Pharmaceutical composition | |
GB9515723D0 (en) | Pharmaceutical composition | |
GB9505369D0 (en) | Pharmaceutical composition | |
GB9515208D0 (en) | Pharmaceutical composition |